STC3141
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for STC3141, covering 2022-04-08 to 2022-04-08. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Safety and Effect of STC3141 Continuous Infusion in Subjects With Severe Corona Virus Disease 2019（COVID-19）Pneumonia [Phase 2]